149 related articles for article (PubMed ID: 12561727)
1. [Flow cytometric analysis of ICRF-193 influence on cell passage through mitosis].
Shatrova A; Aksenov ND; Zenin VV
Tsitologiia; 2002; 44(11):1068-78. PubMed ID: 12561727
[TBL] [Abstract][Full Text] [Related]
2. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay].
Shatrova AN; Aksenov ND; Poletaev AI; Zenin VV
Tsitologiia; 2003; 45(1):59-68. PubMed ID: 12683237
[TBL] [Abstract][Full Text] [Related]
3. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.
Downes CS; Clarke DJ; Mullinger AM; Giménez-Abián JF; Creighton AM; Johnson RT
Nature; 1994 Dec; 372(6505):467-70. PubMed ID: 7984241
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.
Ishida R; Miki T; Narita T; Yui R; Sato M; Utsumi KR; Tanabe K; Andoh T
Cancer Res; 1991 Sep; 51(18):4909-16. PubMed ID: 1654205
[TBL] [Abstract][Full Text] [Related]
5. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells.
Anderson H; Roberge M
Cell Growth Differ; 1996 Jan; 7(1):83-90. PubMed ID: 8788036
[TBL] [Abstract][Full Text] [Related]
6. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine.
Ferguson LR; Whiteside G; Holdaway KM; Baguley BC
Environ Mol Mutagen; 1996; 27(4):255-62. PubMed ID: 8665870
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerase II inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane; ADR-529] and ICRF-159 (Razoxane).
Gorbsky GJ
Cancer Res; 1994 Feb; 54(4):1042-8. PubMed ID: 8313360
[TBL] [Abstract][Full Text] [Related]
8. DNA topoisomerase II is required for the G0-to-S phase transition in Drosophila Schneider cells, but not in yeast.
Hossain MS; Kurokawa K; Akimitsu N; Sekimizu K
Genes Cells; 2004 Oct; 9(10):905-17. PubMed ID: 15461662
[TBL] [Abstract][Full Text] [Related]
9. Differences in inhibition of chromosome separation and G2 arrest by DNA topoisomerase II inhibitors merbarone and VM-26.
Chen M; Beck WT
Cancer Res; 1995 Apr; 55(7):1509-16. PubMed ID: 7882360
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
11. Ku antigen is required to relieve G2 arrest caused by inhibition of DNA topoisomerase II activity by the bisdioxopiperazine ICRF-193.
Muñoz P; Baus F; Piette J
Oncogene; 2001 Apr; 20(16):1990-9. PubMed ID: 11360183
[TBL] [Abstract][Full Text] [Related]
12. Cytological analysis of chromosome structural defects that result from topoisomerase II dysfunction.
Giménez-Abián JF; Clarke DJ
Methods Mol Biol; 2009; 582():189-207. PubMed ID: 19763951
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events.
Ishida R; Sato M; Narita T; Utsumi KR; Nishimoto T; Morita T; Nagata H; Andoh T
J Cell Biol; 1994 Sep; 126(6):1341-51. PubMed ID: 8089169
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerase II-dependent control of the cell cycle progression in root meristems of Allium cepa.
Zabka A; Polit JT; Bernasińska J; Maszewski J
Cell Biol Int; 2014 Mar; 38(3):355-67. PubMed ID: 24302674
[TBL] [Abstract][Full Text] [Related]
15. A topoisomerase II-dependent checkpoint in G2-phase plant cells can be bypassed by ectopic expression of mitotic cyclin B2.
Giménez-Abián JF; Weingartner M; Binarova P; Clarke DJ; Anthony RG; Calderini O; Heberle-Bors E; Moreno Díaz de la Espina S; Bögre L; De la Torre C
Cell Cycle; 2002; 1(3):187-92. PubMed ID: 12429932
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of topoisomerase II delay progress through mitosis and induce a doubling of the DNA content in CHO cells.
Sumner AT
Exp Cell Res; 1995 Apr; 217(2):440-7. PubMed ID: 7698244
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa.
Morris SM; McGarrity LJ; Domon OE; Chen JJ; Casciano DA
Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943
[TBL] [Abstract][Full Text] [Related]
18. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs.
Potter AJ; Rabinovitch PS
Mutat Res; 2005 May; 572(1-2):27-44. PubMed ID: 15790488
[TBL] [Abstract][Full Text] [Related]
19. Can nocodazole, an inhibitor of microtubule formation, be used to synchronize mammalian cells? Accumulation of cells in mitosis studied by two parametric flow cytometry using acridine orange and by DNA distribution analysis.
Nüsse M; Egner HJ
Cell Tissue Kinet; 1984 Jan; 17(1):13-23. PubMed ID: 6692463
[TBL] [Abstract][Full Text] [Related]
20. Modulation of radiation response by inhibiting topoisomerase II catalytic activity.
Mateos S; Hajji N; Pastor N; Cortés F
Mutat Res; 2006 Jul; 599(1-2):105-15. PubMed ID: 16574164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
